Cover Image

Validation of Immune‐Related Adverse Event (irAE) Case Definitions in a Real‐World Lung Cancer Population

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	James S. Heyward, Jodi B. Segal, Hemalkumar B. Mehta, Joseph C. Murray
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pharmacoepidemiology and Drug Safety
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Real‐World Study on Adverse Reactions of Belimumab Based on the FDA Adverse Event Reporting System Database
by: Le Hai, et al.
Published: (2024)

A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid
by: Le Hai, et al.
Published: (2025)

Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
by: W. N. Kelly, et al.
Published: (2024)

Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study
by: Bahar Javdan, et al.
Published: (2024)

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK : A Nested Case–Control and Case‐Crossover Study
by: Donya Moslemzadeh, et al.
Published: (2026)

A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis‐Related Safety Signals
by: Priscilla O. M. V. Lopes, et al.
Published: (2026)

Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the FDA Adverse Event Reporting System ( FAERS ) Database
by: Zhenpo Zhang, et al.
Published: (2025)

Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the FAERS Database
by: Jiayu Yuan, et al.
Published: (2024)

Hepatobiliary Adverse Events Associated With the KRAS p.G12C Inhibitor Sotorasib
by: Connor Frey
Published: (2025)

Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to RxNorm and Anatomical Therapeutic Chemical ( ATC ) Codes
by: Rowan E. Parry, et al.
Published: (2025)

Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study
by: Maeve E. Wickham, et al.
Published: (2024)

Diagnostic Performance of Prostate Cancer Disease‐Specific Phenotypes Identified Using Real‐World Databases: A Systematic Review
by: Ami Vyas, et al.
Published: (2025)

Exploring the Complexity of Real‐World Health Data Record Linkage—An Exemplary Study Linking Cancer Registry and Claims Data
by: Nadja Lendle, et al.
Published: (2025)

Assessing Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Incidence of Major Adverse Cardiovascular Events: A Retrospective Cohort Study
by: Aljoharah M. Algabbani, et al.
Published: (2025)

A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: J. Bradley Layton, et al.
Published: (2025)

Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review
by: Shahd A. Ageeb, et al.
Published: (2024)

Development and Validation of an Endometrial Cancer Algorithm in US Claims Data
by: Kimberly Daniels, et al.
Published: (2026)

Validation Assessment of Privacy‐Preserving Synthetic Electronic Health Record Data: Comparison of Original Versus Synthetic Data on Real‐World COVID‐19 Vaccine Effectiveness
by: Echo Wang, et al.
Published: (2024)

Clarithromycin Versus Azithromycin for Community‐Acquired Pneumonia and the Risk of Major Adverse Cardiovascular Events: A Multicentre Cohort Study Using Data From Canada and Denmark
by: Theis Skovsgaard Itenov, et al.
Published: (2025)

Evaluating the Impact of Data Standardization on Real‐World Data
by: Elizabeth M. Garry, et al.
Published: (2025)

Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Registry Data
by: Paul D. Kruithof, et al.
Published: (2026)

Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer
by: Euloge Clovis Kenne Pagui, et al.
Published: (2025)

Preregistration: A Key to Credible Real‐World Evidence Generation
by: Emma Simonsen, et al.
Published: (2025)

An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer
by: Jessica A. Perhanidis, et al.
Published: (2024)

Identifying COVID ‐19 Disease Severity in Real‐World Data: Implications for Medical Product Effectiveness Studies
by: Mayura U. Shinde, et al.
Published: (2026)

Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study
by: Avery Shuei‐He Yang, et al.
Published: (2024)

Effectiveness of Additional Risk Minimization Measures Related to Interstitial Lung Disease/Pneumonitis With Trastuzumab Deruxtecan Treatment of Breast Cancer in European Countries: Results and Learnings From a Post‐Authorization Safety Survey Among Physicians
by: Angelika Wientzek‐Fleischmann, et al.
Published: (2025)

Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management
by: G. Niklas Norén, et al.
Published: (2025)

Real‐World Data and Real‐World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII
by: Sean Hennessy, et al.
Published: (2025)

TriNetX Dataworks‐ USA : Overview of a Multi‐Purpose, De‐Identified, Federated Electronic Health Record Real‐World Data and Analytics Network and Comparison to the US Census
by: Ellen Stein, et al.
Published: (2025)

The FDA Sentinel Real World Evidence Data Enterprise (RWE‐DE)
by: Rishi J. Desai, et al.
Published: (2024)

Surveillance of Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccines in the Vaccine Adverse Event Reporting System—United States, July 1, 2015–September 30, 2023
by: Pedro L. Moro, et al.
Published: (2026)

Medications for Nausea and Vomiting of Pregnancy and the Risks for Adverse Birth Outcomes
by: Laure Sillis, et al.
Published: (2026)

Empirical Comparison of Exposure Set Definitions in the Prevalent New‐User Design
by: John Tazare, et al.
Published: (2026)

Real‐World Evidence BRIDGE: A Tool to Connect Protocol With Code Programming
by: Albert Cid Royo, et al.
Published: (2024)

Prevalent‐New User Design for Biosimilar Safety Using Saudi Real‐World Data
by: Ohoud Almadani, et al.
Published: (2026)

Peer Review of Real‐World Data Studies and Open Science—Connecting the Last Mile
by: Sengwee Toh
Published: (2024)

Real‐World Evidence of Indapamide‐Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
by: Raseel Alroba, et al.
Published: (2024)

Comparing Different As‐Treated Approaches: A Methodological Study Using Real‐World Data on Psoriasis Treatments
by: Sejun Kim, et al.
Published: (2026)

Validity of ICD‐10‐based algorithms to identify patients with influenza in inpatient and outpatient settings
by: Kirk Benack, et al.
Published: (2024)